Eterna Therapeutics Inc. (NASDAQ:ERNA) Sees Significant Increase in Short Interest
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totalling 36,600 shares, an increase of 10.2% from the August 31st total of 33,200 shares. Approximately 1.3% of the company’s stock are sold short. Based on an […]
More Stories
HC Wainwright Lowers Shattuck Labs (NASDAQ:STTK) to Neutral
HC Wainwright lowered shares of Shattuck Labs (NASDAQ:STTK – Free Report) from a buy rating to a neutral rating in...
Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research note released on Tuesday morning....
ResMed (NYSE:RMD) Earns “Hold” Rating from Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of ResMed (NYSE:RMD – Free Report) in a research report...
Rivian Automotive (NASDAQ:RIVN) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Rivian Automotive (NASDAQ:RIVN – Free Report) in a report released on...
Pulmatrix (NASDAQ:PULM) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research note issued to investors on Tuesday...
Pinnacle Financial Partners (NASDAQ:PNFP) Rating Lowered to Equal Weight at Wells Fargo & Company
Wells Fargo & Company downgraded shares of Pinnacle Financial Partners (NASDAQ:PNFP – Free Report) from an overweight rating to an...